Literature DB >> 20538528

Cystic fibrosis co-existing with trisomy 21.

E L Guy1, D G Peckham, K G Brownlee, S P Conway, T W R Lee.   

Abstract

Previous reports of children with co-existence of cystic fibrosis and full trisomy 21 suggest a very poor prognosis, with the majority of cases dying in infancy and the oldest reported survivor being 6 years of age. We report the case of a young man with genetically confirmed trisomy 21 and homozygous for the F508del cystic fibrosis mutation. Despite the diagnosis of cystic fibrosis being delayed until the age of 2 years he has transitioned to adult services and is now 25 years of age. Currently he has poor lung function and a continuous ambulatory oxygen requirement.
Copyright © 2010 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538528     DOI: 10.1016/j.jcf.2010.05.003

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  5 in total

1.  Three rare diseases in one Sib pair: RAI1, PCK1, GRIN2B mutations associated with Smith-Magenis Syndrome, cytosolic PEPCK deficiency and NMDA receptor glutamate insensitivity.

Authors:  David R Adams; Hongjie Yuan; Todd Holyoak; Katrina H Arajs; Parvin Hakimi; Thomas C Markello; Lynne A Wolfe; Thierry Vilboux; Barbara K Burton; Karin Fuentes Fajardo; George Grahame; Conisha Holloman; Murat Sincan; Ann C M Smith; Gordon A Wells; Yan Huang; Hugo Vega; James P Snyder; Gretchen A Golas; Cynthia J Tifft; Cornelius F Boerkoel; Richard W Hanson; Stephen F Traynelis; Douglas S Kerr; William A Gahl
Journal:  Mol Genet Metab       Date:  2014-04-13       Impact factor: 4.797

2.  Coexistence of meconium ileus with duodenal atresia and trisomy 21 in a newborn: a case report.

Authors:  O W Akinloye; W Truong; M Giacomantonio; D Mateos; W El-Naggar
Journal:  J Perinatol       Date:  2014-11       Impact factor: 2.521

3.  18q deletion in a cystic fibrosis infant, increased morbidity and challenge for correct treatment choices: a case report.

Authors:  Elide Spinelli; Silviana Timpano; Annalisa Fogazzi; Silvia Dester; Susanna Milianti; Rita Padoan
Journal:  Ital J Pediatr       Date:  2011-05-17       Impact factor: 2.638

4.  Is sweat testing for cystic fibrosis feasible in patients with down syndrome?

Authors:  Katharina Ruf; Antonia Demerath; Helge Hebestreit; Steffen Kunzmann
Journal:  BMC Pulm Med       Date:  2018-01-16       Impact factor: 3.317

5.  Ivacaftor for the Treatment of Cystic Fibrosis Coexisting with Trisomy 21: A Case Report.

Authors:  Edward Charbek; Ghassan Kamel; Ravi P Nayak
Journal:  Cureus       Date:  2019-11-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.